EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark NX was filed as Word mark on 08/15/2023 at the European Union Intellectual Property Office.
It was registered as a trademark on 02/21/2024.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 018913832 |
| Application date | August 15, 2023 |
| Publication date | November 14, 2023 |
| Entry date | February 21, 2024 |
| Expiration date | August 15, 2033 |
Trademark owner
Tödistrasse 46a
8810 Horgen
CH
8810 Horgen
CH
Trademark representatives
Großbeerenstraße 71 1. Hof, Remise rechts
10963 Berlin
DE
goods and services
1
Diagnostic biomarkers for analytical, research and scientific use; Diagnostic biomarkers for in vitro testing for scientific use; Diagnostic biomarkers for use in assessment of genomic analysis for scientific use; Diagnostic biomarkers for use in assessment of individual diagnoses of cancer; Diagnostic preparations for science or research; Diagnostic reagents for science or research Diagnostic reagents for the diagnosis of diseases; Chemicals for the production of medical diagnostic reagents, particularly for cancer research
5
Reactants for medical diagnosis; Preparations for medical diagnosis; Diagnostic reagents for medical or veterinary use in in vitro diagnosis; Reactants for medical diagnosis, particularly for usage with spatial single-cell proteomics Reagents for diagnostic tests for medical use; diagnostic test reagents for veterinary use; diagnostic preparations for medical use; diagnostic radiopharmaceutical preparations; diagnostic substances for medical use; pharmaceutical products, medical and veterinary preparations; Pharmaceuticals for the treatment of cancer; Pharmaceutical preparations and compositions for the treatment and prevention of cancer; Pharmaceutical preparations; Pharmaceutical preparations for the diagnosis of diseases; Pharmaceutical preparations for diagnosis; Pharmaceutical preparations for diagnostic purposes; Pharmaceutical preparations for individual medical diagnosis Pharmaceutical preparations for medical test kits; Pharmaceutical preparations for medical test kits for use in oncology; Pharmaceutical preparations for medical test kits for cancer diagnosis; Pharmaceutical preparations for medical test kits for individual medical diagnosis; Diagnostic test kits for use in oncology; Diagnostic test kits for cancer diagnosis; Diagnostic test kits for individual medical diagnosis
9
Recorded computer programs for use in cancer diagnosis; Downloadable computer programs for use in cancer diagnosis; Recorded computer programs for use in oncology; Downloadable computer programs for use in oncology; Downloadable software applications for Medical and scientific research in the field of cancer treatment and diagnosis; Downloadable and recorded computer programs using machine learning in the field of medical diagnosis and research, particularly for cancer research, treatment and diagnosis; Software for the analysis of medical data, particularly for cancer research, treatment and diagnosis; Software for the digital representation of tumors and tumor features; Software for high-resolution digital image representation of the molecular composition of cellular anomalies; Software for high-resolution digital image representation of a digital tumor; Downloadable and recorded computer programs using machine learning in the field of medical diagnosis and research, particularly for cancer research, treatment and diagnosis; Software for the analysis of medical data, particularly for cancer research, treatment and diagnosis
10
Apparatus for tumour diagnosis; Medical apparatus for machine learning-based spectrum analysis of human blood plasma; Scanners for medical diagnosis; Apparatus for clinical diagnosis, Spectrum analyzers for use in medical diagnosis; Trace material analyzers for medical use in diagnosis; Apparatus used in implementing diagnosis tests designed to detect abnormal genetic mutations in proteins; Diagnostic oncology apparatus for medical use; Diagnostic, examination, and monitoring equipment; Medical tests kits for the use in oncology; Medical test kits for cancer diagnosis; Medical test kits for individual medical diagnosis
42
Cancer research; cancer diagnosis research; Research in the field of Proteomics; Oncological research; research in the field of oncological diagnostics; Technical data analysis services; Development of personalized diagnostics products for cancer treatment; Software-as-a-Service [SaaS] for use in cancer diagnosis; Platform-as-a-Service [PaaS] for use in cancer diagnosis; Software-as-a-Service [SaaS] for use in oncology; Platform-as-a-Service [PaaS] for use in oncology; Software-as-a-Service [SaaS] for medical and scientific research in the field of cancer treatment and diagnosis; Platform-as-a-Service [PaaS] for medical and scientific research in the field of cancer treatment and diagnosis; Software-as-a-Service [SaaS] using machine learning in the field of medical diagnosis and research, particularly for cancer research, treatment and diagnosis; Platform-as-a-Service [PaaS] using machine learning in the field of medical diagnosis and research, particularly for cancer research, treatment and diagnosis; Software-as-a-Service [SaaS] for the analysis of medical data, particularly for cancer research, treatment and diagnosis; Platform-as-a-Service [PaaS] for the analysis of medical data, particularly for cancer research, treatment and diagnosis; Software as-a-Service [SaaS] for the digital representation of tumours and tumour features; Platform-as-a-Service [PaaS] for the digital representation of tumours and tumour features; Software as-a-Service [SaaS] for high-resolution digital image representation of the molecular composition of cellular anomalies; Platform-as-a-Service [PaaS] for high-resolution digital image representation of the molecular composition of cellular anomalies Software as-a-Service [SaaS] for high-resolution digital image representation of digital tumors; Platform-as-a-Service [PaaS] for high-resolution digital image representation of digital tumors
44
Pharmaceutical and diagnostical consulting, particularly in the field of oncology; Pharmaceutical and diagnostical consulting for businesses in the medical field; Pharmaceutical and consulting for cancer treatment; Disease diagnosis services; Cancer diagnosis services, particularly for enabling personalized and individual medical care; Disease diagnosis services, particularly in the field of oncology; Disease diagnosis services in the field of proteomics; Medical analysis services for cancer diagnosis and prognosis; Remote monitoring of medical data for medical diagnosis; Medical analysis for the diagnosis and treatment of persons; Remote monitoring of medical data for medical diagnosis and treatment; Medical testing services relating to the diagnosis and treatment of disease; Providing information in the field of cancer prevention, screening, diagnosis and treatment; Medical diagnosis and treatment of cancer; Medical diagnostic services (testing and analysis); Medical diagnostic services for the indication of individual treatments; Medical diagnostic services for the indication of individual cancer treatments; Medical diagnostic services for the indication of individual treatments in the field of oncology; providing information concerning diagnostic, prophylactic and therapeutic properties of pharmaceutical and biological products for prevention and treatment of diseases, disorders and conditions; medical services; veterinary services; hygienic care for human beings; hygienic care for animals
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| April 15, 2024 | Transfer / Change of address, Published | ||
| March 20, 2024 | Transfer / Change of address, Published |
ID: 11018913832